Brachytherapy in Treating Patients With Recurrent Prostate Cancer

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Prostate Cancer

In brief

RATIONALE: Radiation therapy uses high-energy radiation to damage tumor cells. Brachytherapy uses radioactive material that is placed directly into or near the tumor. Brachytherapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of brachytherapy in treating patients who have recurrent prostate cancer that has not responded to standard therapy.

Key facts

Study ID

NCT00005939

Run by

Center for Molecular Medicine

Starts

1999-11-01

Last updated by the study team

2013-11-06

Who can join

Age: 21 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Center for Molecular Medicine — Garden City, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.